
Editor-in-Chief
Maria Spies
University of Iowa, Carver College of Medicine, USA
Editorial Board
NAR Molecular Medicine now indexed in the Directory of Open Access Journals (DOAJ)
We are pleased to share that NAR Molecular Medicine has been accepted into DOAJ!
View the DOAJ record here, and consider submitting your next paper.
Introducing NAR Molecular Medicine

About NAR Molecular Medicine
NAR Molecular Medicine is a cutting-edge, fully open access new journal in the NAR family portfolio. The journal publishes original research and critical reviews at the intersection of nucleic acid biology, therapeutics, and the molecular mechanisms of disease. The journal considers papers within this broad scope from all areas of clinical medicine, pathology, molecular and cellular biology, structure-activity investigations related to disease, computation, and drug discovery.
Find out more

Fully Open Access
NAR Molecular Medicine is fully open access (OA) along with the rest of the NAR journals. OA is a key part of how the NAR journals supports their mission to disseminate high-quality science for the furtherment of the nucleic acids research field.
Oxford University Press has a growing number of Read and Publish agreements with institutions and consortia which provide funding for open access publishing. Find out if your institution is participating.

Meet the Editor-in-Chief & Editorial Board
Maria Spies, PhD, professor of biochemistry, molecular biology, and radiation oncology, Carver College of Medicine, University of Iowa, serves as Editor-in-Chief of NAR Molecular Medicine. Learn more about the team behind the journal.
View the full Editorial Board

Never miss the latest research
Register to receive email alerts as soon as new content is published with NAR Molecular Medicine.
Sign up